Navidea Biopharmaceuticals, Inc. Gains 32.78%
Wed, Aug 16, 2023 at 07:32 PM
Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) rocketted at $0.1, representing a gain of 32.8%. On Wed, Aug 16, 2023, NAVB:NYSEMKT hit a New 2-Week High of $0.1. The stock appeared on our News Catalysts scanner on Tue, Aug 01, 2023 at 08:35 AM in the 'INVESTOR UPDATE' category. From Wed, Aug 02, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Fri, Jun 16, 2023 at $0.17 with a volume of 126M+.
About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
Top 10 Gainers:
- Esports Technologies Inc. (EBET:NASDAQ), 109.16%
- Digital Brands Group Inc. (DBGI:NASDAQ), 91.27%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 80.11%
- EzFill Holdings Inc. (EZFL:NASDAQ), 64.65%
- micromobility.com Inc Cl A (MCOM:NASDAQ), 35.35%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 32.78%
- DLocal Limited (DLO:NASDAQ), 31.94%
- JX Luxventure Limited (JXJT:NASDAQ), 30.97%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 30.85%
- Aurora Acquisition Corp. (AURC:NASDAQ), 28.55%